Visby Medical Expands Series E Round to Over $135 Million

Visby Medical announced that it expanded its over-subscribed Series E financing round to include an additional $35 million for a total of over $135 million raised in the round. The additional investment was led by Lightrock, who joined existing Series E investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and J Ventures.

The additional investment will be used to enable Visby Medical to scale production capacity, further expand the product menu to include advanced respiratory health tests, antimicrobial resistance panels, and deliver the power of PCR diagnostics to consumers at-home.

Read Press Release

1809 Capital Closes Investment With Cloverleaf

Coaching for Everyone - Cloverleaf provides automated personal and team coaching delivered to the tools you work in every day. CloverLeaf has solutions for three categories. These categories are Team Leaders & Managers, Enterprise Leaders, and Coaches & Consultants. They use their own software to provide coaching to these categories. You can schedule a demo to learn how to use CloverLeaf and then obtain the product through a subscription service. Replaces one time use psychographic assessments: augments coaching consultancies with ongoing real time daily use SaaS platform.

Read Press Release

1809 Capital Closes Investment With Visby Medical

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.

Read Press Release